Organization | Sinovac Biotech Co., Ltd

Sinovac Biotech Co., Ltd Report issue

For profit Phase 1 Phase 3 Phase 4

Founded: Beijing China (1999)

Status: Defunct (2018)

Organization Overview

First Clinical Trial

2005

NCT00356798

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Sinovac Biotech (Chile) SpA | Sinovac Biotech (Colombia) S.A.S. | Sinovac Biotech Co., Ltd | Sinovac Biotech (Hong Kong) Limited | Sinovac (Dalian) Vaccine Technology Co., Ltd. | Sinovac Research and Development Co., Ltd.

Active Ingredients

Drugs in Phase 4 Trials (19)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (5 trials)

aluminium chloride (1 trial)

aluminum hydroxide (Gaviscon) (1 trial)

attenuated live hepatitis A vaccine (1 trial)

covid-19 vaccine (vero cells) (4 trials)

ev71 vaccine (12 trials)

hepatitis a vaccine, inactivated (vaqta) (6 trials)

hepatitis-a virus (inactivated) / hepatitis-b surface antigen (twinrix) (1 trial)

hepatitis b vaccine (recombinant) (Recombivax) (3 trials)

inactivated covid-19 vaccine (9 trials)

inactivated influenza vaccine (20 trials)

Inactivated polio virus - Enhanced (IPOL) (2 trials)

inactivated sabin strain polio virus (3 trials)

inactivated SARS-Cov-2 vaccine (9 trials)

live attenuated varicella vaccine (Varivax) (9 trials)

measles, mumps, and rubella vaccine (MMR) (2 trials)

methylprednisolone (medrol) (1 trial)

split virion influenza vaccine (3 trials)

vasopressin (vasostrict) (1 trial)

Drugs in Phase 3 Trials (6)

Bivalent group A and C meningococcal vaccine (Menomune-A/C) (1 trial)

bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (2 trials)

coronavac (1 trial)

live attenuated mumps vaccine (Jeryl Lynn strain) (2 trials)

omicron covid-19 vaccine (vero cell), inactivated (1 trial)

polio, inactivated poliovirus vaccine (Salk Vaccine) (1 trial)

Drugs in Phase 1 Trials (1)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Chickenpox (Phase 3)

Enterovirus Infections (Phase 1)

Foot-and-Mouth Disease (Phase 4)

Hand, Foot and Mouth Disease (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Herpes Zoster (Phase 3)

Infections (Phase 3)

Influenza, Human (Phase 4)

Mouth Diseases (Phase 4)

Mumps (Phase 4)

Pneumococcal Infections (Phase 3)

Poliomyelitis (Phase 3)

Virus Diseases (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 83
# of Trial APIs: 26